Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
05 nov. 2024 09h01 HE
|
Turnstone Biologics Corp.
Turnstone Biologics presents preclinical data highlighting potential for Selected TIL therapy in solid tumors at SITC 2024